by Christopher R. LoPalo, Partner AstraZeneca has withdrawn Andexxa (andexanet alfa) from the United States market effective December 22, 2025. Patients who experienced adverse health outcomes, complications, or injuries related…
Category Archives: Pharmaceutical Litigation
Prescription drugs are meant to help patients recover from or cope with encumbering medical conditions. Unfortunately, not all prescription drugs are made or distributed with patients’ best interests in mind; many cause undue harm, injury, and even death. If you are the victim of a pharmaceutical drug that’s caused you harm that you would not have suffered but for the medication, you have the right to pursue a civil action. At Napoli Shkolnik, PLLC our attorneys can help you to determine who is liable for your injuries, and file a claim to recover damages for economic and noneconomic losses.
By Christopher R. LoPalo, Partner As someone who has represented countless individuals and families affected by talc-related cancers, I’m often asked whether these cases are winding down. The short and…
The opioid overdose rate has quadrupled since 1999. Fatal and near-fatal drug overdoses obviously affect the person who takes the drugs. These incidents also disrupt the addict’s family. Furthermore, they…
Quite simply, over a thousand victims have filed Ozempic lawsuits because the company spent almost a billion dollars promoting the drug, but didn’t warn users of the serious side effects….
In one of the latest Ozempic developments, the PA MDL committee appointed retired judge Lawrence F. Stengel to oversee discovery in the case. In July and August of 2024, the…
Current Orleans Parish Sherriffs’ Office deputies Thomya Bryant, 25, and Giona Gibson, 22, were suspended after an internal investigation into the introduction of illegal contraband at the jail that launched…
Polypharmacy is Medspeak for taking more than one prescription medication at a time. About one in five Americans over age 49 is a polypharmicist, of sorts. Ideally, doctors and pharmacists…
Following a Food and Drug Administration finding that the decongestant phenylephrine is no more effective than a placebo, a Minnesota consumer filed a class action lawsuit against Kenvue, Inc. and…
Under pressure from the Food and Drug Administration, Horizon added a stronger hearing loss warning label to one of its best-selling drugs. The warning advises purchasers about the potential for…
Complaint Claims Opaque, Conspiratorial Kickback Scheme Exponentially Increased Defendants’ Profits at the Expense of Plaintiff, its Plan Members and Other Payers Napoli Shkolnik has filed a lawsuit on behalf of…









